Prenetics Global (PRE) Net Income towards Common Stockholders (2021 - 2026)
Prenetics Global's (PRE) quarterly Net Income towards Common Stockholders came in at -$8.9 million in Q2 2026, up 26.9% year-over-year from -$7.0 million in Q2 2025, and up 62.07% quarter-over-quarter from -$23.5 million in Q1 2026.
Analysis
Prenetics Global (PRE) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Prenetics Global (PRE) has reported Net Income towards Common Stockholders for 6 consecutive years, with -$8.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 26.9% year-over-year to -$8.9 million in Q2 2026; TTM through Jun 2026 was -$47.3 million, a 3.83% increase from a year earlier, with the FY2025 full-year figure at $744538.7, up 101.61% from the prior year.
- Net Income towards Common Stockholders was -$8.9 million for Q2 2026 at Prenetics Global, up from -$23.5 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$7.4 million in Q3 2025 and troughed at -$195.3 million in Q4 2022.
- A 5-year average of -$34.4 million and a median of -$13.1 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders plunged 1851.36% in 2022 and soared 86.5% in 2023, its largest moves.
- Over 5 years, Net Income towards Common Stockholders stood at -$195.3 million in 2022, then surged by 67.88% to -$62.7 million in 2023, then jumped by 73.94% to -$16.3 million in 2024, then soared by 54.11% to -$7.5 million in 2025, then dropped by 18.71% to -$8.9 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$8.9 million (Q2 2026), -$23.5 million (Q1 2026), and -$7.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 574.00 Mn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 75.03 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | -15.74 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | -10.50 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | -12.91 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | -19.27 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 15.90 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | -8.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.90 Mn |
| Mar 31, 2026 | -23.47 Mn |
| Dec 31, 2025 | -7.50 Mn |
| Sep 30, 2025 | -7.41 Mn |
| Jun 30, 2025 | -12.18 Mn |
| Mar 31, 2025 | -10.39 Mn |
| Dec 31, 2024 | -16.34 Mn |
| Sep 30, 2024 | -10.25 Mn |
| Jun 30, 2024 | -10.92 Mn |
| Mar 31, 2024 | -9.00 Mn |
| Dec 31, 2023 | -62.72 Mn |
| Sep 30, 2023 | -14.00 Mn |
| Jun 30, 2023 | -20.04 Mn |
| Mar 31, 2023 | -10.50 Mn |
| Dec 31, 2022 | -195.30 Mn |
| Sep 30, 2022 | -17.72 Mn |
| Jun 30, 2022 | -148.42 Mn |
| Mar 31, 2022 | -33.52 Mn |
| Dec 31, 2021 | -173.75 Mn |
| Sep 30, 2021 | -80.41 Mn |